Related Experiment Video
Updated: Aug 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antimicrobial Use in U.S. Hospitals: Comparison of 2015 and 2023 Prevalence Surveys
Barbara C Keino1, Taniece Eure1, Rebecca Alkis Ramirez1
1Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Background:
Prevalence surveys in U.S. hospitals in 2011 and 2015 showed that half of inpatients received antimicrobials on the survey day or day before. We repeated the survey in 2023 to assess changes in antimicrobial use (AU).
Methods:
Ten Emerging Infections Program (EIP) sites recruited up to 25 hospitals each, prioritizing prior participants. EIP staff reviewed medical records of randomly selected inpatients from the survey day morning census and documented AU on the survey day or day before. We compared AU and stewardship characteristics between 2023 and 2015 and used multivariable log-binomial regression to identify factors associated with AU in 2023.
Results:
Antimicrobial stewardship programs were present in 215/218 hospitals in 2023 (98.6%) compared with 158/199 (79.4%) in 2015. Of 13 653 patients in 2023, 6785 (49.7%) received ≥1 antimicrobial on the survey day or day before. Among 151 hospitals participating in both surveys, overall AU prevalence was similar in 2015 and 2023 (49.2% vs 49.1%), with decreases in neonatal critical care (23.4% to 17.1%) and increases in mother-baby units (24.4% to 32.8%). Fluoroquinolone use declined (9.2% to 2.8%), while third- or fourth-generation cephalosporin use increased (12.3% to 18.6%). In 2023, higher AU was associated with patient factors (medical devices, inpatient location, obesity, 4-17 day hospital stays, and suburban residence) and hospital factors (Northeast and South regions, AU audits).
Conclusions:
One in two inpatients received an antimicrobial in 2023, similar to 2015. However, changes in AU by inpatient location and antimicrobial class suggest evolving prescribing practices and may inform targeted surveillance and stewardship efforts.
Insights
Antimicrobial use in U.S. hospitals remained stable at approximately 50% of inpatients between 2015 and 2023. Despite overall stability, shifts in prescribing patterns by location and drug class indicate evolving practices.
Area of Science:
- Infectious Diseases
- Hospital Epidemiology
- Public Health
Background:
- Hospital antimicrobial use (AU) prevalence was assessed in 2011 and 2015, revealing approximately half of inpatients received antimicrobials.
- A follow-up survey was conducted in 2023 to evaluate current antimicrobial prescribing trends in U.S. hospitals.
Purpose of the Study:
- To assess changes in inpatient antimicrobial use (AU) prevalence in U.S. hospitals between 2015 and 2023.
- To identify factors associated with current antimicrobial prescribing practices.
Main Methods:
- Ten Emerging Infections Program (EIP) sites participated, surveying up to 25 hospitals each.
- Medical records of randomly selected inpatients were reviewed to document AU on the survey day or day prior.
- Multivariable log-binomial regression was used to identify factors associated with AU in 2023.
Main Results:
- Antimicrobial stewardship programs were present in 98.6% of hospitals in 2023, up from 79.4% in 2015.
- Overall AU prevalence was 49.7% in 2023, similar to 2015 (49.2% in participating hospitals).
- Significant shifts observed include decreased AU in neonatal critical care and increased AU in mother-baby units, alongside a decline in fluoroquinolone use and an increase in third- or fourth-generation cephalosporins.
Conclusions:
- Inpatient antimicrobial use remains high, with approximately one in two patients receiving treatment.
- Evolving prescribing practices are evident in shifts by inpatient location and antimicrobial class.
- Findings can inform targeted surveillance and antimicrobial stewardship interventions.
Related Concept Videos
Antimicrobial Effectiveness
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Automated Microbial Diagnostics
Hand hygiene
Hand washing...
